{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:07Z","timestamp":1762431127386},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cll.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:45:04Z","timestamp":1457484304000},"page":"407-419","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy"],"prefix":"10.1016","volume":"36","author":[{"given":"Deborah M.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam F.","family":"Borgida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cll.2016.01.011_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3201\/eid0911.030098","article-title":"Toxoplasma gondii infection in the United States, 1999\u20132000","volume":"9","author":"Jones","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib3","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1056\/NEJM199406303302604","article-title":"Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection","volume":"330","author":"Guerina","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.siny.2009.02.003","article-title":"Infection and stillbirth","volume":"14","author":"McClure","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.cll.2016.01.011_bib5","first-page":"57","article-title":"Preventing congenital toxoplasmosis","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cll.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/590149","article-title":"Management of Toxoplasma gondii infection during pregnancy","volume":"47","author":"Montoya","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","article-title":"Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection","volume":"66","author":"Wilson","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.cll.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.clp.2005.04.011","article-title":"Diagnosis and management of toxoplasmosis","volume":"32","author":"Montoya","year":"2005","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.cll.2016.01.011_bib9","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/JCM.27.9.2133-2135.1989","article-title":"Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy","volume":"27","author":"Del Bono","year":"1989","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.cll.2016.01.011_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jcp.45.6.483","article-title":"Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies","volume":"45","author":"Ashburn","year":"1992","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/JCM.35.1.174-178.1997","article-title":"False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test","volume":"35","author":"Liesenfeld","year":"1997","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cll.2016.01.011_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1067\/mob.2001.108341","article-title":"Confirmatory serologic testing for acute toxoplasmosis and the rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers","volume":"184","author":"Liesenfeld","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib13","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1373\/clinchem.2005.051532","article-title":"Enzyme immunoassay (EIA)\/enzyme-linked immunosorbent assay (ELISA)","volume":"51","author":"Lequin","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2016.01.011_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10096-006-0204-1","article-title":"Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women","volume":"25","author":"Lefevre-Pettrazzoni","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib15","series-title":"Diagnostic imaging obstetrics","first-page":"14","article-title":"Toxoplasmosis","author":"Byrne","year":"2011"},{"key":"10.1016\/j.cll.2016.01.011_bib16","first-page":"296","article-title":"Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis","volume":"97","author":"Romand","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9378(99)70311-X","article-title":"Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters","volume":"181","author":"Foulon","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0074-02762009000200038","article-title":"Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis","volume":"104","author":"Bessieres","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.cll.2016.01.011_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001684","article-title":"Treatments for toxoplasmosis in pregnancy","author":"Peyron","year":"1999","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cll.2016.01.011_bib20","first-page":"1","article-title":"Use of antiprotozoan and anthelmintic drugs during pregnancy: side effects and contra-indications","volume":"25","author":"Cook","year":"1992","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cll.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","article-title":"Safety and toxicity of sulfadoxine\/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment","volume":"30","author":"Peters","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.cll.2016.01.011_bib22","first-page":"e55","article-title":"Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation","volume":"52","author":"Bachmeyer","year":"2006","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cll.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10647440300025512","article-title":"Toxoplasmosis-related knowledge and practices among pregnant women in the United States","volume":"11","author":"Jones","year":"2003","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1089\/jwh.2008.1288","article-title":"Obstetrician\/gynecologists\u2019 knowledge, attitudes, and practices regarding prevention of infections in pregnancy","volume":"18","author":"Ross","year":"2009","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.cll.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/JPM.2004.039","article-title":"Prevention of toxoplasmosis during pregnancy\u2013an epidemiologic survey over 22 consecutive years","volume":"32","author":"Breugelmans","year":"2004","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.cll.2016.01.011_bib26","series-title":"Harrison\u2019s principles of internal medicine","first-page":"1478","article-title":"Parvovirus infections","author":"Brown","year":"2012"},{"key":"10.1016\/j.cll.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","article-title":"The role of parvovirus B19 in anaplastic crisis and erythema infectiosum (fifth disease)","volume":"154","author":"Chorba","year":"1986","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinids\/10.5.1005","article-title":"Human parvovirus B19: historical and clinical review","volume":"10","author":"Thurn","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2016.01.011_bib29","first-page":"733","article-title":"Human parvovirus in pregnancy","volume":"72","author":"Rodis","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/JCM.24.4.522-526.1986","article-title":"Detection antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6733","key":"10.1016\/j.cll.2016.01.011_bib31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/bmj.300.6733.1166","article-title":"Prospective study of human parvovirus (B19) infection in pregnancy. Public health laboratory service working party on fifth disease","volume":"300","author":"Hall","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.cll.2016.01.011_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1471-0528.2010.02749.x","article-title":"Parvovirus B19 infection in human pregnancy","volume":"118","author":"Lamont","year":"2011","journal-title":"BJOG"},{"issue":"4 Pt 1","key":"10.1016\/j.cll.2016.01.011_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0002-9378(90)90681-V","article-title":"Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study","volume":"163","author":"Rodis","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.cll.2016.01.011_bib34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/593190","article-title":"Parvovirus B19 infection in fetal deaths","volume":"47","author":"Riipinen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-9378(11)91430-6","article-title":"Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction","volume":"167","author":"Kovacs","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.cll.2016.01.011_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1701-2163(15)30390-X","article-title":"Parvovirus B19 infection in pregnancy","volume":"36","author":"Crane","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.cll.2016.01.011_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006254-199704000-00023","article-title":"Infection by parvovirus B 19 during pregnancy: a review","volume":"52","author":"Levy","year":"1997","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.cll.2016.01.011_bib38","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2007.10.788","article-title":"The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia","volume":"198","author":"Moise","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.cll.2016.01.011_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jcu.20613","article-title":"Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of nonimmune hydrops","volume":"37","author":"Borna","year":"2009","journal-title":"J\u00a0Clin Ultrasound"},{"issue":"4","key":"10.1016\/j.cll.2016.01.011_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9378(98)70203-0","article-title":"Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the society of perinatal obstetricians","volume":"79","author":"Rodis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.011_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1469-0705.1999.13030161.x","article-title":"Intrauterine management of fetal parvovirus B19 infection","volume":"13","author":"Schild","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.cll.2016.01.011_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7863\/jum.1998.17.9.547","article-title":"Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion","volume":"17","author":"Odibo","year":"1998","journal-title":"J\u00a0Ultrasound Med"},{"issue":"1","key":"10.1016\/j.cll.2016.01.011_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.AOG.0000249611.67873.94","article-title":"Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection","volume":"109","author":"Nagel","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.011_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0029-7844(97)00575-9","article-title":"Long-term outcome of children following maternal human parvovirus B19 infection","volume":"91","author":"Rodis","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.cll.2016.01.011_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2016.01.011_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.cll.2016.01.011_bib47","series-title":"Vaccines for the 21st Century: a tool for decision making","first-page":"460","article-title":"Vaccines for the 21st Century: a tool for decision making","author":"Institute of Medicine Committee to Study Priorities for Vaccine Development","year":"2000"},{"key":"10.1016\/j.cll.2016.01.011_bib48","series-title":"Viral infections in obstetrics and gynecology","first-page":"35","article-title":"Cytomegalovirus","author":"Pass","year":"1999"},{"key":"10.1016\/j.cll.2016.01.011_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.011_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cll.2016.01.011_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?","volume":"135","author":"Fowler","year":"1999","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cll.2016.01.011_bib52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-0528.2007.01651.x","article-title":"Congenital cytomegalovirus infection following primary maternal infection in the third trimester","volume":"115","author":"Gindes","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.cll.2016.01.011_bib53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1471-0528.2004.00328.x","article-title":"Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease","volume":"112","author":"Daiminger","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.cll.2016.01.011_bib54","first-page":"881","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk","volume":"95","author":"Leisnard","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib55","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.cll.2016.01.011_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CDLI.4.4.483-486.1997","article-title":"Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional Western blot and nine commercially available assays","volume":"4","author":"Lazzarotto","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cll.2016.01.011_bib57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.humimm.2004.02.006","article-title":"Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection","volume":"65","author":"Lazzarotto","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cll.2016.01.011_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CDLI.4.4.469-473.1997","article-title":"Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects","volume":"4","author":"Lazzarotto","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cll.2016.01.011_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/vim.2000.13.137","article-title":"Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnancy women at risk of transmitting cytomegalovirus","volume":"13","author":"Lazzarotto","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.cll.2016.01.011_bib60","first-page":"283","article-title":"Cordocentesis","volume":"15","author":"Weiner","year":"1988","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.cll.2016.01.011_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0029-7844(97)00084-7","article-title":"Prenatal diagnosis of fetal primary cytomegalovirus infection","volume":"89","author":"Lipitz","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mob.2000.106347","article-title":"Prenatal diagnosis of symptomatic congenital cytomegalovirus infection","volume":"183","author":"Guerra","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1469-0705.1998.12030151.x","article-title":"The megalovirus","volume":"12","author":"Ville","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"380","key":"10.1016\/j.cll.2016.01.011_bib64","first-page":"e1","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.011_bib65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcv.2005.09.015","article-title":"Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome","volume":"35","author":"Pass","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cll.2016.01.011_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1096-9071(199609)50:1<9::AID-JMV3>3.0.CO;2-5","article-title":"Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum","volume":"50","author":"Reullan-Eugene","year":"1996","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cll.2016.01.011_bib67","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.011_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jp.7211854","article-title":"Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant","volume":"25","author":"Muller","year":"2008","journal-title":"J\u00a0Perinatol"},{"issue":"466","key":"10.1016\/j.cll.2016.01.011_bib69","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2009.01.001","article-title":"Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis","volume":"201","author":"Cahill","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T18:58:29Z","timestamp":1655233109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271216300117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0272271216300117"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.011","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}